Sniecinski Megan
Insider CIK 1781480 · PRAX Chief Operating Officer · BCRX Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | A Award | 2026-05-14 | 2026-05-19 | 89 | $167.94 | $14.9K | 28,664 | SEC↗ |
| PRAX Praxis Precision Medicines | F Tax w/h | 2026-01-12 | 2026-01-13 | 885 | $275.74 | $244.0K | 28,530 | SEC↗ |
| PRAX Praxis Precision Medicines | F Tax w/h | 2026-01-10 | 2026-01-12 | 1,087 | $288.45 | $313.5K | 29,415 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2026-01-08 | 2026-01-12 | 7,700 | — | $0 | 7,700 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award | 2026-01-08 | 2026-01-12 | 9,625 | — | $0 | 30,502 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-15 | 2020-12-17 | 225,000 | — | $0 | 225,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-12-17 | 2019-12-19 | 202,000 | — | $0 | 202,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-12-17 | 2019-12-26 | 240,000 | — | $0 | 240,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-11-18 | 2019-11-18 | 45,000 | $1.45 | $65.3K | 45,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-07-01 | 2019-07-03 | 500,000 | — | $0 | 500,000 | SEC↗ |